Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-10-000421
Filing Date
2010-02-11
Accepted
2010-02-11 13:46:06
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q zk1007892.htm 10-Q 1710247
2 EXHIBIT 3.1 exhibit_3-1.htm EX-3.1 27715
3 EXHIBIT 3.2 exhibit_3-2.htm EX-3.2 28689
4 EXHIBIT 31.1 exhibit_31-1.htm EX-31.1 10556
5 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 10723
6 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 6276
7 EXHIBIT 32.2 exhibit_32-2.htm EX-32.2 6409
  Complete submission text file 0001178913-10-000421.txt   1802292
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Filer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31392 | Film No.: 10590827
SIC: 2836 Biological Products, (No Diagnostic Substances)